Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The benefit of current stem cell transplantation therapy for myocardial infarction is limited
by low survival rate for stem cell. The purpose of this study is to test whether intensive
Atorvastatin therapy can improve the outcome of patients with impaired left ventricle
function after myocardial infarction who underwent intracoronary transfer of autologous bone
marrow cells.
Phase:
Phase 2
Details
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital